Skip to main content
NCBI home page
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1964;31(3):379–392.

Studies on a strain of chloroquine-resistant Plasmodium falciparum from Viet-Nam*

Robin D Powell, George J Brewer, Richard L Degowin, Alf S Alving
PMCID: PMC2555117  PMID: 14267747

Abstract

This report presents the results of chemotherapeutic studies carried out with non-immune volunteers infected with a strain of Plasmodium falciparum from Viet-Nam, termed the Viet-Nam (Sn.) strain, under conditions of study precluding reinfection. Nine volunteers received, during acute clinical attacks, three-day courses of chloroquine, seven receiving 1500 mg of chloroquine base orally, one 3000 mg of chloroquine base orally, and one 2160 mg of chloroquine base intramuscularly. Volunteers also received, again during acute clinical attacks, various regimens of hydroxychloroquine (1500 mg base), amodiaquine (1400 mg base), mepacrine (2198 mg base), proguanil (2610 mg base), or 377-C-54 (1500 or 2500 mg base). These drugs failed to effect radical cure of the infections, both before and after passage of the strain through mosquitos.

On the other hand, the administration of either 50 mg of pyrimethamine daily for three days or 1620 mg of quinine base (1935 mg of quinine sulfate) daily for 10 days effected radical cure of the infections. The administration of 1620 mg of quinine base daily for seven days failed to effect radical cure of the infections in two of five volunteers. Under the particular experimental conditions employed, intramuscular injection of CI-501 (a repository preparation of a highly active metabolite of proguanil) did not exert a demonstrable protective effect against the Viet-Nam (Sn.) strain of P. falciparum.

Full text

PDF
379

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alving A. S., Craige B., Pullman T. N., Whorton C. M., Jones R., Eichelberger L. PROCEDURES USED AT STATEVILLE PENITENTIARY FOR THE TESTING OF POTENTIAL ANTIMALARIAL AGENTS. J Clin Invest. 1948 May;27(3 Pt 2):2–5. doi: 10.1172/JCI101956. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BOX E. D., BOX Q. T., YOUNG M. D. CHLOROQUINE-RESISTANT PLASMODIUM FALCIPARUM FROM PORTO VELHO, BRAZIL. Am J Trop Med Hyg. 1963 May;12:300–304. doi: 10.4269/ajtmh.1963.12.300. [DOI] [PubMed] [Google Scholar]
  3. BRUCE-CHWATT L. J., CHARLES L. J. First field trial of 377 C 54, a new antimalarial compound. Br Med J. 1957 Jul 6;2(5035):23–26. doi: 10.1136/bmj.2.5035.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. COATNEY G. R., CONTACOS P. G., LUNN J. S., KILPATRICK J. W., ELDER H. A. THE EFFECT OF A REPOSITORY PREPARATION OF THE DIHYDROTRIAZINE METABOLITE OF CHLORGUANIDE, CI-501, AGAINST THE CHESSON STRAIN OF PLASMODIUM VIVAX IN MAN. Am J Trop Med Hyg. 1963 Jul;12:504–508. doi: 10.4269/ajtmh.1963.12.504. [DOI] [PubMed] [Google Scholar]
  5. COATNEY G. R., CONTACOS P. G., LUNN J. S., KILPATRICK J. W., ELDER H. A. THE EFFECT OF A REPOSITORY PREPARATION OF THE DIHYDROTRIAZINE METABOLITE OF CHLORGUANIDE, CI-501, AGAINST THE CHESSON STRAIN OF PLASMODIUM VIVAX IN MAN. Am J Trop Med Hyg. 1963 Jul;12:504–508. doi: 10.4269/ajtmh.1963.12.504. [DOI] [PubMed] [Google Scholar]
  6. CONTACOS P. G., ELDER H. A., COATNEY G. R. THERAPEUTIC TRIALS OF A DIHYDROXYNAPHTHALENE (377C54) AGAINST PLASMODIUMFALCIPARUM AND PLASMODIUM VIVAX INFECTIONS IN HUMAN VOLUNTEERS. Am J Trop Med Hyg. 1963 Jul;12:513–518. doi: 10.4269/ajtmh.1963.12.513. [DOI] [PubMed] [Google Scholar]
  7. GALVAO A. L., GUSMAO H. H., JUAREZ E., SCHMID A. W., RICCI A., de MELLO J. [Malaria in Amapa. Observations on the abnormal behavior of Plasmodium falciparum in treatment with 4-aminoquinolines]. Arq Fac Hig Saude Publica Univ Sao Paulo. 1961;15-16:201–244. [PubMed] [Google Scholar]
  8. HASKINS W. T. A simple qualitative test for chloroquine in urine. Am J Trop Med Hyg. 1958 Mar;7(2):199–200. doi: 10.4269/ajtmh.1958.7.199. [DOI] [PubMed] [Google Scholar]
  9. MOORE D. V., LANIER J. E. Observations on two Plasmodium falciparum infections with an abnormal response to chloroquine. Am J Trop Med Hyg. 1961 Jan;10:5–9. doi: 10.4269/ajtmh.1961.10.5. [DOI] [PubMed] [Google Scholar]
  10. POWELL R. D., BREWER G. J., ALVING A. S., MILLAR J. W. STUDIES ON A STRAIN OF CHLOROQUINE-RESISTANT PLASMODIUM FALCIPARUM FROM THAILAND. Bull World Health Organ. 1964;30:29–44. [PMC free article] [PubMed] [Google Scholar]
  11. RAY A. P., SINGH N., GUPTA GP SEN, MISRA B. G. Therapeutic response to a newer antimalarial, 377-C-54. J Indian Med Assoc. 1959 May 16;32(10):398–401. [PubMed] [Google Scholar]
  12. SCHMIDT L. H., ROSSAN R. N., FISHER K. F. THE ACTIVITY OF A REPOSITORY FORM OF 4,6-DIAMINO-1(P-CHLOROPHENYL)-1,2-DIHYDRO-2,2-DIMETHYL-S-TRIAZINE AGAINST INFECTIONS WITH PLASMODIUM CYNOMOLGI. Am J Trop Med Hyg. 1963 Jul;12:494–503. doi: 10.4269/ajtmh.1963.12.494. [DOI] [PubMed] [Google Scholar]
  13. THOMPSON P. E., OLSZEWSKI B. J., ELSLAGER E. F., WORTH D. F. LABORATORY STUDIES ON 4,6DIAMINO-1-(P-CHLOROPHENYL)-1,2-DIHYDRO-2,2-DIMETHYL-S-TRIAZINE PAMOATE (CI-501) AS A REPOSITORY ANTIMALARIAL DRUG. Am J Trop Med Hyg. 1963 Jul;12:481–493. doi: 10.4269/ajtmh.1963.12.481. [DOI] [PubMed] [Google Scholar]
  14. YOUNG M. D. Amodiaquine and hydroxychloroquine resistance in Plasmodium falciparum. Am J Trop Med Hyg. 1961 Sep;10:689–693. doi: 10.4269/ajtmh.1961.10.689. [DOI] [PubMed] [Google Scholar]
  15. YOUNG M. D., CONTACOS P. G., STITCHER J. E., MILLAR J. W. DRUG RESISTANCE IN PLASMODIUM FALCIPARUM FROM THAILAND. Am J Trop Med Hyg. 1963 May;12:305–314. doi: 10.4269/ajtmh.1963.12.305. [DOI] [PubMed] [Google Scholar]
  16. YOUNG M. D. Failure of chloroquine and amodiaquine to suppress Plasmodium falciparum. Trans R Soc Trop Med Hyg. 1962 May;56:252–256. doi: 10.1016/0035-9203(62)90164-5. [DOI] [PubMed] [Google Scholar]
  17. YOUNG M. D., MOORE D. V. Chloroquine resistance in Plasmodium falciparum. Am J Trop Med Hyg. 1961 May;10:317–320. doi: 10.4269/ajtmh.1961.10.317. [DOI] [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES